Chemical investigation of a crinoid Himerometra magnipinna has afforded three anthraquinones (1-3), including one new metabolite, (+)-rhodoptilometrin (1). The structures of these compounds were elucidated on the basis of their spectroscopic data and the absolute configuration of 1 was further confirmed by single-crystal X-ray diffraction analysis. In the in vitro anti-inflammatory effects test, compound 2 was found to significantly inhibit the accumulation of the pro-inflammatory iNOS protein of the LPS-stimulated RAW264.7 macrophage cells.
Over the past 40 years, a number of anthraquinones have been isolated from crinoids [1] [2] [3] [4] [5] [6] [7] [8] . Some of these display a variety of biological activities, such as cytotoxicity to some cancer cell lines [1, 3] . Recently, in our search for biologically active secondary metabolites from a crinoid Himerometra magnipinna, we isolated one new anthraquinone , (+)-rhodoptilometrin (1) and two known anthraquinones, 3-propyl-1,6,8-trihydroxy-9,10-anthraquinone (2) [1] and 3-propionyl-1,6,8-trihydroxy-9,10-anthraquinone (3) ( Figure  1 ) [5] . The ability of 1-3 to inhibit the expression of the proinflammatory iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2) proteins in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells was also evaluated. The HR-ESI-MS of compound 1 exhibited a molecular ion peak at m/z 337.0686 ([M + Na] + ), consistent with the molecular formula C 17 H 14 O 6 and implying eleven degrees of unsaturation. The structure of 1 and all of the 1 H and 13 C NMR spectral data (Table 1) were assigned by the assistance of 2D NMR ( 1 H-1 H COSY and HMBC) experiments. The spectral data of 1 were in full agreement with that of a known anthraquinone, rhodoptilometrin, which was isolated from a crinoid Colobometra perspinosa [1] . However, the antipodal rotation value of 1 {[α] 25 D +18 (c 1.0, MeOH)} in comparison with that of rhodoptilometrin {[α] 20 D -22 (c 0.1, MeOH)}, suggested compound 1 to be the enantiomer of rhodoptilometrin [1] . Moreover, in the previous report, the authors gave a planar structure or S-configuration for C-1′ [1, 8] . Therefore, the presence of one secondary alcohol of 1 allowed us to determine Finally, the anti-inflammatory activity of 1-3 against the accumulation of pro-inflammatory iNOS and COX-2 proteins in RAW264.7 macrophage cells stimulated with LPS was evaluated using immunoblot analysis. The result clearly depicts an upregulation of iNOS and COX-2 proteins in the LPS-stimulated murine macrophage cell line. Only iNOS was significantly inhibited by both compounds 1 and 2 at 10-50 µM, respectively (Figure 2 ).
Experimental
General: IR, Varian Digilab FTS 1000 Fourier transform infrared spectrophotometer; Optical rotation, Jasco P-1010 digital polarimeter; NMR, Varian Unity INOVA 500 FT-NMR instrument; ESIMS and HRESIMS, Bruker APEX II mass spectrometer. Gravity column chromatography was performed on silica gel (230-400 mesh, Merck). TLC was carried out on precoated Kieselgel 60 F254 plates (0.2 mm, Merck) and compounds were visualized by spraying with 10% H 2 SO 4 solution followed by heating. HPLC was performed using a system comprised of a Hitachi L-7100 pump (Hitachi, Tokyo, Japan) and a Rheodyne 7725 injection port (Rheodyne, Cotati, CA, USA). A preparative normal phase column (Hibar 250 × 21.2 mm, Supelco, silica gel 60, 5 μm) was used for HPLC.
Animal material:
A specimen of H. magnipinna (specimen no. MC2008-2) was collected by scuba divers at a depth of 10-15 m from coral reefs off the coast of Pingtung, Taiwan, in July 2008. A voucher sample was deposited in the National Museum of Marine Biology and Aquarium, Taiwan.
Extraction and isolation:
H. magnipinna was stored frozen and then freeze dried. The freeze-dried material (800 g) was minced and extracted exhaustively with EtOAc (5 × 2 L). The EtOAc extract was evaporated to yield a residue (28.0 g), which was subjected to open CC on silica gel eluting with an n-hexane-EtOAc gradient and EtOAc-acetone gradient, to give 12 fractions. Fraction 10 was further separated by silica gel CC with gradient elution (n-hexaneacetone, 3:1) to afford 3 sub-fractions (A1-A3). Sub-fraction A2 was also separated by normal phase HPLC using n-hexane-acetone (3:1) to afford 2 (20.0 mg) and 3 (5.0 mg). Compound 1 (1216 mg) was obtained from sub-fraction A3 using normal phase HPLC (n-hexane-acetone, 2:1). [9] : A suitable orange prismatic crystal of 1 was obtained from a solution of ethyl acetate. Crystal data and experimental details: C 17 H 16 O 7 , Mr = 332.30, crystal size 0.25 × 0.10 × 0.10 mm, crystal system orthorhombic, space group P2 1 (#4), with a = 6.7551(5) Å, b = 11.8259(5) Å, c = 17.9035(8) Å, V = 1430.2(2) Å, 3 , Z = 4, D calcd = 1.543 g/cm 3 , λ (Cu, kα) = 1.54178 Å. Intensity data were measured on a Bruker APEX-II CCD diffractometer equipped with a micro-focus Cu radiation source and a Montel mirror up to θ max of 66.2° at 100 K. All 2454 reflections were collected. The structure was solved by direct methods and refined by a full-matrix least-squares procedure. The refined structural model converged to a final R1 = 0.0286, wR2 = 0.0769 for 2338 observed reflection [I>2σ(I)] and 222 variable parameters. The absolute configuration was determined by Flack's method with Flack's parameter determined as 0.13(14).
X-ray diffraction analysis

In vitro anti-inflammatory assay:
The macrophage (RAW264.7) cell line was purchased from ATCC. In vitro anti-inflammatory activities of compounds 1-3 were measured by examining the inhibition of lipopolysaccharide (LPS) induced upregulation of iNOS (inducible nitric oxide synthetase) and COX-2 (cyclooxygenase-2) proteins in macrophage cells using Western blotting analysis [10] .
